ACELYRIN
Los Angeles
About ACELYRIN
ACELYRIN is a biopharma company focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating the development and commercialization of promising drug candidates and by leveraging its expertise to rapidly advance these medicines to patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Total funding: $558.0M
- Funding stage: M&A
- Last round: Series C (Sep 2022)
- Ticker: nasdaq:SLRN
- Website: acelyrin.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/acelyrin-61781 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.